Beyond Borders: Mapping HCV Care Challenges in DC and Across the Nation

This module provides a comprehensive exploration of hepatitis C (HCV) transmission, prevention, and treatment. Participants will review demographics of high-risk populations, learn about the revolutionary impact of direct-acting antivirals (DAAs), and evaluate strategies for universal HCV testing in reducing transmission rates and improving public health outcomes.

Learning Objectives

At the end of this module, you will be able to:

• Analyze Hepatitis C demographics to identify hidden patterns and target high-risk populations effectively.
• Describe the revolutionary impact of direct-acting antivirals (DAAs) on Hepatitis C treatment outcomes.
• Explain the significance of universal HCV testing in reducing transmission rates and enhancing public health outcomes.
• Discuss the rationale behind universal HCV treatment and its role in reducing disease burden.
• Navigate simplified HCV treatment guidelines and apply them to patient-centered approaches.
• Evaluate strategies for treating and preventing HCV transmission, focusing on high-risk populations and overcoming barriers to care.

Please note that continuing education credits are not available for this module.